Exposure Of Bisphenol Analogues In Chronic Kidney Disease and Dialysis Patients

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University154 enrolled

Overview

In this retrospective study, the serum levels of Bisphenol A (BPA) and three BPA analogs, namely, bisphenol B (BPB), bisphenol S (BPS), and bisphenol F (BPF), in patients with CKD, patients on dialysis therapy and healthy control were investigated to find out if BPA and BPA analogs accumulates in patients with chronic kidney disease (CKD), and if hemodialysis filters contribute to bisphenol burden in patients on hemodialysis (HD).

Study Type

OBSERVATIONAL

Enrollment

154

Conditions

Chronic Kidney Diseases Hemodialysis Complication

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age 18; informed consent Exclusion Criteria: * absence of active inflammatory, infectious, malignant diseases, acute chronic kidney disease, or pregnancy at the initiation or during the study

Locations (1)

Shanghai Ninth People's Hospital

Shanghai, China

Outcomes

Primary Outcomes

Death

Time frame: 2017.01-2018.06

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.